Ex vivo Manufactured Neutrophils for Treatment of Neutropenia—A Process Economic Evaluation

Ex vivo Manufactured Neutrophils for Treatment of Neutropenia—A Process Economic Evaluation

Neutropenia is a common side-effect of acute myeloid leukemia (AML) chemotherapy characterized by a critical drop in neutrophil blood concentration. Neutropenic patients are prone to infections, experience poorer clinical outcomes, and require expensive medical care. Although transfusions of donor n...

Full description

Bibliographic Details
Main Authors: Mario A. Torres-Acosta, Richard P. Harrison, Elizabeth Csaszar, Marco Rito-Palomares, Marion E. G. Brunck
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-03-01
Series:Frontiers in Medicine
Subjects:
bioprocess modeling
neutrophils
granulocytes transfusion
acute myeloid leukemia
economic analysis
cost of goods
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2019.00021/full

Internet

https://www.frontiersin.org/article/10.3389/fmed.2019.00021/full

Similar Items